The Anti-Monopoly Committee of the State Council published the Anti-Monopoly Guideline for the Active Pharmaceutical Ingredient Industry, prohibiting both horizontal and vertical monopoly agreements and the Japan FTC announced it had closed its investigation into Rakuten.